Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In pivotal clinical trials, these agents typically reduce hemoglobin A1c by 0.81.5% from baseline, with greater reductions observed at higher doses and in patients with higher baseline A1c values
Reconstitution and laboratory handling A 40 mg retatrutide vial reconstituted with 2 mL of bacteriostatic water yields a working concentration of 20 mg/mL a concentrated stock that suits protocols requiring smaller injection volumes per dose, or research workflows where having more compound per vial reduces reconstitution frequency
Serving Size: 1 Capsule Amount Per Serving: Vitamin D (as Cholecalciferol)
Results from a Phase III trial met the criteria for non-inferiority and superiority compared to piperacillin/tazobactam in the primary outcome of clinical cure and microbiological eradication in patients with complicated UTIs
